NOVARTIS AG (NVSEF)
Clinical trial NCT05622708 updates: 1. completion date: 2028-06-13 → 2028-04-04 2. primary completion date: 2028-04-19 → 2028-02-08
Clinical trial NCT05622708 updates: 1. completion date: 2028-06-13 → 2028-04-04 2. primary completion date: 2028-04-19 → 2028-02-08
📉 **NEGATIVE** • Medium confidence analysis (75%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (12%) **Content type:** Clinical